DPP4 and atrial fibrillation: Optimizing the timing of adjunctive therapies, such as β-blockers, metformin, or dipeptidyl peptidase-4 (DPP-4) inhibitors, may further reduce AF recurrence, and dual therapy could represent an alternative strategy to conventional sequential administration [68,69].